×
Bayer Total Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer total assets for the quarter ending December 31, 2024 were
$119.951B
, a
4.67% decline
year-over-year.
Bayer total assets for 2024 were
$119.951B
, a
4.67% decline
from 2023.
Bayer total assets for 2023 were
$125.827B
, a
4.37% decline
from 2022.
Bayer total assets for 2022 were
$131.57B
, a
7.51% decline
from 2021.
View More
Bayer Total Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer total assets for 2024 were
$119.951B
, a
4.67% decline
from 2023.
Bayer total assets for 2023 were
$125.827B
, a
4.37% decline
from 2022.
Bayer total assets for 2022 were
$131.57B
, a
7.51% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$796.4B
Johnson & Johnson (JNJ)
$379.5B
AbbVie (ABBV)
$306B
Novo Nordisk (NVO)
$260.6B
Roche Holding AG (RHHBY)
$248.1B
Novartis AG (NVS)
$234.2B
Merck (MRK)
$196.7B
Sanofi (SNY)
$128.6B
Pfizer (PFE)
$125.6B
Innoviva (INVA)
$1.1B